March 25, 2021
Movano Inc. Appoints Medtech Industry Veteran John Mastrototaro, PhD, as CEO
Read More 9
March 25, 2021
Movano Inc. Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
Read More 9
March 23, 2021
Movano Inc. Prices $42.5 Million Public Offering of Common Stock
Read More 9
September 24, 2020
GLOBALFOUNDRIES and Movano Inc. Partner to Advance Needle-Free Continuous Glucose Monitoring Technology
Read More 9
August 29, 2020
Movano Inc. Closes Bridge Financing Round at $12.5M
Read More 9
July 14, 2020
Movano Inc. Exits Stealth Mode and Secures $10M in Additional Funding to Transform Glucose Monitoring with Non-Invasive Technology
Read More 9
